Clinical Trials Directory

Trials / Unknown

UnknownNCT02509390

Hyperfibrinogenemia After Major Trauma

Hyperfibrinogenemia Within the First Days After Major Trauma : Kinetic, Functionality, Impact of Fibrinogen Replacement Therapy and Trauma, Thrombosis Risk

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Assessment of the evolution of fibrinogen plasma level within the first ten days after major trauma in order to determine prevalence of hyperfibrinogenemia (Fg \> 4 g/L) and its time to onset.

Detailed description

In this study, investigators daily investigate fibrinogen plasma levels and fibrinogen antigen in severe trauma patients (Injury severity score \> 15) within the first ten days. Investigators then modelize hyperfibrinogenemia profiles according to severity of injuries and physiopathologic mechanisms. Finally, investigators determine predisposing risk factors to develop hyperfibrinogenemia and assess the impact of fibrinogen replacement therapy in initial phase of management of major trauma.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood samplesInvestigators analyze hematological parameters with blood sampled daily in severe trauma patients

Timeline

Start date
2014-09-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2015-07-28
Last updated
2015-07-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02509390. Inclusion in this directory is not an endorsement.